Filing Details

Accession Number:
0001209191-20-055045
Form Type:
4
Zero Holdings:
No
Publication Time:
2020-10-16 15:56:14
Reporting Period:
2020-10-14
Accepted Time:
2020-10-16 15:56:14
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1741830 Kronos Bio Inc. KRON () 4
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1361712 Otello Stampacchia 888 Boylston St.
Suite 1111
Boston MA 02199
Yes No Yes No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2020-10-14 1,606,220 $0.00 1,625,671 No 4 C Indirect By Omega Fund V, LP
Common Stock Acquisiton 2020-10-14 1,376,313 $0.00 3,001,984 No 4 C Indirect By Omega Fund V, LP
Common Stock Acquisiton 2020-10-14 366,299 $16.15 3,368,283 No 4 C Indirect By Omega Fund V, LP
Common Stock Acquisiton 2020-10-14 450,000 $19.00 3,818,283 No 4 P Indirect By Omega Fund V, LP
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 C Indirect By Omega Fund V, LP
No 4 C Indirect By Omega Fund V, LP
No 4 C Indirect By Omega Fund V, LP
No 4 P Indirect By Omega Fund V, LP
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Series Seed Preferred Stock Disposition 2020-10-14 1,522,484 $0.00 1,606,220 $0.00
Common Stock Series A Preferred Stock Disposition 2020-10-14 1,304,563 $0.00 1,376,313 $0.00
Common Stock Convertible Promissory Note Disposition 2020-10-14 0 $0.00 366,299 $16.15
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
0 No 4 C Indirect
0 No 4 C Indirect
0 2022-02-20 No 4 C Indirect
Footnotes
  1. Each share of Series Seed Preferred Stock and Series A Preferred Stock (the "Preferred Stock") automatically converted into 1.055 shares of Common Stock upon the closing of the Issuer's initial public offering. The Preferred Stock had no expiration date.
  2. The reporting person, Claudio Nessi and Anne-Mari Paster are the directors of Omega Fund V GP Manager, Ltd. ("Omega Manager"), which is the sole general partner of Omega V Fund GP, L.P. ("Omega GP"), which is the sole general partner of Omega Fund V, L.P. ("Omega L.P."). The reporting person may be deemed to share voting and dispositive power over the shares held by Omega L.P. The reporting person, together with Omega GP and Omega Manager, disclaims beneficial ownership of the shares held by Omega L.P. except to the extent of his pecuniary interest therein.
  3. The convertible promissory note automatically converted into shares of the Issuer's common stock upon the closing of the Issuer's initial public offering.